Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
On Jan. 28, 2024, a freezing-cold night in New York, Kevin Eriksen made a commitment to himself: He was going to walk ...
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.
Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback